Gainers
- IN8bio INAB shares increased by 69.5% to $1.78 during Monday's pre-market session. The company's market cap stands at $44.3 million.
- Aclarion ACON stock increased by 67.6% to $1.24. The market value of their outstanding shares is at $9.7 million.
- ZyVersa Therapeutics ZVSA shares rose 25.75% to $2.1. The market value of their outstanding shares is at $19.3 million.
- Applied Therapeutics APLT stock moved upwards by 17.33% to $1.11. The market value of their outstanding shares is at $53.4 million.
- IDEAYA Biosciences IDYA shares moved upwards by 17.22% to $17.5. The company's market cap stands at $846.9 million.
- Avalo Therapeutics AVTX stock rose 17.03% to $3.4. The market value of their outstanding shares is at $44.8 million.
Losers
- Femasys FEMY stock fell 20.1% to $0.72 during Monday's pre-market session. The market value of their outstanding shares is at $9.4 million.
- Foghorn Therapeutics FHTX stock declined by 18.31% to $5.49. The market value of their outstanding shares is at $229.5 million.
- Aziyo Biologics AZYO shares fell 11.86% to $1.71. The market value of their outstanding shares is at $27.6 million.
- Leap Therapeutics LPTX shares declined by 10.51% to $0.33. The company's market cap stands at $39.1 million.
- NovaBay Pharmaceuticals NBY stock fell 10.26% to $1.4. The market value of their outstanding shares is at $2.8 million.
- Onconova Therapeutics ONTX stock decreased by 8.95% to $0.99. The company's market cap stands at $20.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
APLTApplied Therapeutics Inc
$0.8949-12.3%
AVTXAvalo Therapeutics Inc
$8.91-1.87%
FEMYFemasys Inc
$1.08-1.74%
FHTXFoghorn Therapeutics Inc
$5.143.21%
INABIN8bio Inc
$0.25003.99%
LPTXLeap Therapeutics Inc
$2.914.68%
NBYNovaBay Pharmaceuticals Inc
$0.51001.17%
ZVSAZyVersa Therapeutics Inc
$1.06-14.4%
IDYAIDEAYA Biosciences Inc
$25.613.31%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in